- Home
- NL vs ABEO Comparison
NL vs ABEO Comparison
Compare NL & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NL | ABEO |
|---|---|---|
| Founded | 1891 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.0M | 280.2M |
| IPO Year | 1994 | 2005 |
Fundamental Metrics
Financial Performance| Metric | NL | ABEO |
|---|---|---|
| Price | $5.96 | $4.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $18.75 |
| AVG Volume (30 Days) | 51.4K | ★ 978.0K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | ★ 10.45% | N/A |
| EPS Growth | N/A | ★ 38.74 |
| EPS | N/A | ★ 1.35 |
| Revenue | ★ $158,285,000.00 | $2,998,000.00 |
| Revenue This Year | $15.75 | N/A |
| Revenue Next Year | $2.44 | $1,589.77 |
| P/E Ratio | ★ N/A | $3.71 |
| Revenue Growth | 8.46 | ★ 258.18 |
| 52 Week Low | $5.04 | $3.93 |
| 52 Week High | $9.27 | $7.54 |
Technical Indicators
Market Signals| Indicator | NL | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 44.88 | 43.97 |
| Support Level | $5.89 | $4.87 |
| Resistance Level | $6.55 | $5.60 |
| Average True Range (ATR) | 0.37 | 0.20 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 24.05 | 22.97 |
Price Performance
Historical ComparisonAbout NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.